13%
Reduction in release time for high-value APIs
A multinational chemical-pharmaceutical company faced recurring challenges in its Quality Control (QC) labs, where complex API analyses, long release cycles, and increasing workload pressures regularly triggered requests for additional headcount. By applying EFESO’s proprietary QC lab optimization framework, the organization achieved simultaneous gains in productivity without compromising quality.
Industry: Chemicals
Industry: Life Sciences
Service: Manufacturing
Service: Operational Excellence
Service: Smart Factory
A multinational chemical-pharmaceutical company producing both proprietary and generic drugs. Its Quality Control labs manage complex analytical requirements for high-value Active Pharmaceutical Ingredients (APIs), including highly sensitive injectable products requiring up to 130 hours of analysis and several weeks of release procedures.
Quality Control labs were under pressure to manage fluctuating workloads, long release cycles, and rising demands for additional personnel, all while ensuring high service levels for high-value APIs.
The EFESO approach delivered measurable improvements across all labs, including substantial productivity gains and increased process reliability.
13%
Reduction in release time for high-value APIs
10%
Productivity increase (release time per batch)
17%
Reduction in required FTEs through optimized flow and better workload leveling
EFESO deployed a two-phase methodology combining deep assessment and hands-on implementation in the most critical API lab.
Comprehensive QC Lab Assessment
Full Implementation in High-Value API Lab